valproid acid plus corticosteroids
Phase 3Small molecule
valproid acid plus corticosteroids is one of 11 small molecule programs targeting Tropical Spastic Paraparesis. It is currently in Phase 3.
1
Indications
1
Total Trials
0
Active Trials
10
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
12 competitors in Tropical Spastic Paraparesis
#DrugCompanyPhaseTrials
1Neoral
NovartisApproved
Epivir
GGlaxo Dba Glaxosmithkline
Approved
Retrovir
BBp Consulting, Inc
Approved
Depakote
AbbViePhase 3
Poteligeo
KKyowa Kirin, Inc.
Phase 3
Ciclosporin
NovartisPhase 3
Tamibarotene
SSyros Pharmaceuticals
Phase 3
Remicade
OOrganon and Co
Phase 2
Aubagio
SanofiPhase 1
valproid acid plus corticosteroids
UUniversity of Sao Paulo
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- UUniversity of Sao Paulo